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Abstract
Background: The control of typhoid fever being an important public health concern in low and middle income
countries, improving typhoid surveillance will help in planning and implementing typhoid control activities such as
deployment of new generation Vi conjugate typhoid vaccines.
Methods: We conducted a systematic literature review of longitudinal population-based blood culture-confirmed
typhoid fever studies from low and middle income countries published from 1st January 1990 to 31st December
2013. We quantitatively summarized typhoid fever incidence rates and qualitatively reviewed study methodology
that could have influenced rate estimates. We used meta-analysis approach based on random effects model in
summarizing the hospitalization rates.
Results: Twenty-two papers presented longitudinal population-based and blood culture-confirmed typhoid fever
incidence estimates from 20 distinct sites in low and middle income countries. The reported incidence and
hospitalizations rates were heterogeneous as well as the study methodology across the sites. We elucidated how
the incidence rates were underestimated in published studies. We summarized six categories of under-estimation
biases observed in these studies and presented potential solutions.
Conclusions: Published longitudinal typhoid fever studies in low and middle income countries are geographically
clustered and the methodology employed has a potential for underestimation. Future studies should account for
these limitations.
Keywords: Typhoid fever, Surveillance, Systematic literature review, Low and middle income countries, Under-
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Background
Typhoid fever is a serious systemic illness transmitted
through fecal-oral route and known to affect population
having limited water and sanitation infrastructure [1].
Presence of long-term carrier status and variable level of
risk factors such as contaminated water, food and poor
sanitation conditions in different geographical regions
often causes patchy outbreaks and uneven disease
distributions [2]. The disease is considered an important
public health problem and the World Health Organization
(WHO) has recommended vaccination with existing Vi
polysaccharide vaccine targeting high-risk areas where
typhoid fever is a problem [1]. For targeted vaccination
strategies, it is essential to have a robust surveillance to
understand the distribution of typhoid fever by geography
and population groups. Besides quantifying disease bur-
den, surveillance is helpful in tracking changes in level of
incidence, anti-microbial resistance and the impact of ty-
phoid fever control interventions. The importance of sur-
veillance has increased with imminent availability of new
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generation typhoid conjugate vaccines [3], which may ne-
cessitate revisiting of WHO policies on vaccination
strategies.
It is challenging to measure the real disease burden of
typhoid fever based on a surveillance system. First, ty-
phoid fever is common in locations with poor water and
sanitation, where infrastructure and resources required
for good surveillance are limited. Sustaining long-term
effective surveillance needs continued commitment of
health system and scarce resources. Second, because ty-
phoid fever often clinically resembles other febrile ill-
nesses, it is clinically misdiagnosed in many regions of
the world where malaria and dengue are highly prevalent
[1]. In remote and resource poor settings without la-
boratory surveillance systems, typhoid fever outbreaks as
well as routine cases are under reported [4]. Third, the
current typhoid fever diagnostics have limitations in
terms of availability and reliability which exemplifies the
misrepresentation of the disease [2]. Typhoid fever is
often diagnosed clinically or using antibody titers in rou-
tine settings at hospitals and health facilities. The diag-
nostic sensitivity and specificity of antibody titer based
tests is less than optimal [5]. Blood culture is highly spe-
cific but its sensitivity is lower, ranging from 40 to 80 %
[6], and poses several operational and laboratory chal-
lenges [5]. Forth, only a proportion of all febrile cases at
community may choose to visit health care facilities
where surveillance is conducted underrepresenting true
number of cases at the community. This is because
people with febrile illness may opt for different service
providers such as alternative health facilities, private
practitioners, pharmacies, traditional healers or self-
medication or no treatment [7].
Despite these challenges, global donors, policy and fi-
nancing bodies and local decision makers look for pre-
cise information on size and seriousness of typhoid fever
problem. Therefore, it is critical to identify and list stud-
ies that tried to minimize surveillance challenges while
measuring the incidence of typhoid fever. Such studies
will help in pinpointing the geographical locations where
typhoid continues to be an important problem so that
interventions can be targeted. We conducted a system-
atic literature review to identify blood culture-confirmed
typhoid fever studies that try to represent the disease
burden in underlying community. Based on the litera-
ture review we summarized the current challenges and
future surveillance needs for improving the precision of
disease burden estimates.
Method
We performed the systematic literature review and pre-
sented results as per the Preferred Reporting Items for
Systematic Reviews and Meta-analyses (PRISMA) state-
ment (please see additional file 1).
Search strategy and selection criteria
We undertook a systematic literature review of
population-based, longitudinal studies of blood culture-
confirmed typhoid fever conducted in low and middle
income countries [8] published from 1st January 1990 to
31st December 2013 using a predefined protocol. The
search involved PubMed and Embase as primary elec-
tronic databases for identification of publications. Pan
American Health Organisation (PAHO) and WHO
websites were utilized to identify additional publications.
The key words used were (“typhoid” OR “typhoid fever”
OR “Salmonella Typhi” OR “S. Typhi” OR “salmonella
infection” OR “enteric fever”) AND (“incidence” OR
“rate” OR “frequency” OR “prevalence” OR “morbidity”
OR “burden” OR “surveillance” OR “epidemiology”). The
search was limited to English language and studies of
human individuals. The detailed inclusion and exclusion
criteria are given below (Table 1). The search was inde-
pendently conducted by two researchers and the results
were compared. Any differences between two re-
searchers were resolved based on discussion and agree-
ment, if unresolved, third independent researcher made
the final decision. All selected papers were reviewed by a
third researcher before data extraction to confirm its ad-
herence to inclusion criteria and to limit the risk-of bias.
In the final list, we included distinct population-based
longitudinal studies that used blood culture for typhoid
fever confirmation in incidence estimation irrespective
of intensity of surveillance.
Table 1 Inclusion and exclusion criteria for systematic literature
review
Inclusion Criteria
• Published from 1st January, 1990 to 31st December 2013
• Listed in Pubmed OR Embase OR WHO OR PAHO data base
• Conducted in low and middle income countries based on World Bank
definition [8]
• Blood culture was used for typhoid fever confirmation
• Diagnostic health facility covers clearly defined population OR a health
care utilization survey provides a population denominator
• Study conducted in human subjects
• Study published in English
Exclusion Criteria
• Surveillance that did not deploy blood culture for typhoid fever
confirmation
• Results from intervention arm of clinical trials
• Typhoid fever outbreak reports
• Government reports based on selected sentinel health facilities
• Studies estimating incidence based on mathematical models
• Hospital based surveillance where denominator is not defined or
health care utilization survey was not conducted
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Data analysis
We used both qualitative and quantitative and methods
in data analysis. First, we qualitatively scrutinized study
methodology that could have influenced incidence rate
estimates. Based on the description presented in the
paper, we identified the potential reasons for typhoid
fever underestimation and determine the potential cor-
rection approaches. Then, we extracted data related to
typhoid fever incidence and hospitalization rates from
selected studies and calculated incidence correction fac-
tors for each study. Finally, the incidence rates were pre-
sented based on two estimates: a) without correcting
limitations of surveillance methods, and b) after correct-
ing the limitations of surveillance methods.
We did not include incidence rates from clinical trials
because they did not present sufficient details on sur-
veillance to correct for methodological limitations. The
hospitalization rate was estimated based on the number
of hospitalizations among confirmed typhoid fever
cases during the surveillance which was not corrected
for its methodological limitations. We used meta-
analysis approach in summarizing the hospitalization
rates, where weighted mean was estimated by regions
using random effects model. Qualitative information
such as methodology, challenges faced, strengths and
limitations were descriptively summarized for consider-
ations in future surveillance.
Results
Our systematic literature search resulted in 3747 English
publications from 1990 to 2013 (Fig. 1). After reviewing
titles and abstract 3635 irrelevant publications were ex-
cluded and full text articles for remaining 112 papers
were obtained. Of them, 77 papers did not match inclu-
sion criteria as they did not use blood culture for case
confirmation and were excluded. Of 35 selected studies,
13 either did not represent a community or used model-
ing methods to estimate typhoid incidence. Finally we
identified and analyzed data from 22 papers.
The 22 papers presented population-based blood
culture-confirmed typhoid fever incidence estimates
from 20 distinct sites in low and middle income coun-
tries [9–30] (Fig. 2). Based on United Nations region
classification [31], most of published estimates were
from Asia, with five estimates from the Southern Asia
region [15, 17–21, 29, 30], four from the South-Eastern
Asia region [15, 22–25], and two from the Eastern Asia
region [15, 16]. The rest of the estimates were collected
from Africa, with three sites in the Eastern Africa region
[13, 14], two from Northern Africa [9, 10] and one from
Western Africa [11, 12]. Except four estimates from
Chile [27, 28], Southern Africa [26] and Indonesia [22],
rest had incidence data collected post 1990s. Three pa-
pers from Pakistan [15, 19, 20] presented incidence data
for different time period from same sites. Similarly, two
Fig. 1 PRISMA diagram for systematic literature review conducted to identify population based longitudinal typhoid fever studies
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papers each presented data for different periods from
same sites in Ghana [11, 12], India [15, 29], Bangladesh
[18, 30], Indonesia [15, 23] and Vietnam [24, 25].
Of the 22 studies, eight were of clinical trials re-
stricted to certain age groups such as school children
and young adults while excluding children below 2
years [16, 20, 22, 25–29]. These trials described pre-
existing known high incidence typhoid fever locations.
The papers focused on clinical trial related descrip-
tions, surveillance related information was often
sketchy without detailed methodological information
and were excluded from detailed analysis.
The descriptions on surveillance below included 14
papers representing 15 distinct sites. This includes
multi-site studies [13, 15] and, multiple studies from
same sites in Ghana [11, 12], Bangladesh [18, 30] and
Pakistan [15, 19] which used standardized methodologies
(Table 2). Of the total 15 studies, seven (46 %) were lo-
cated urban sites, four (27 %) in rural and remaining
four (27 %) in mixed urban-rural sites (Table 2). The
surveillance period ranged from November 1995 to
December 2010 while the duration of individual study
varied from 4 months to 36 months. The studies covered
4.0 million populations for 281 months and identified
63,220 eligible cases. Analysis included 41,325 subjects
who provided blood samples and 1149 were found posi-
tive for Salmonella Typhi infection.
When full text papers of selected studies were meticu-
lously reviewed, we identified several reasons to argue
that longitudinal studies underestimate typhoid fever in-
cidence owing to the study design and implementation,
and categorized them into six groups (Table 3). The
most common problem is that surveillance sites do not
capture all febrile cases because there are multiple ser-
vice providers at the community such as private practi-
tioners, traditional healers etc. who are not included in
the study. We note that most passive typhoid fever sur-
veillance studies relied upon only public health facilities.
A commonly used inclusion criterion, febrile syn-
drome (see Table 2) is another potential source of inci-
dence underestimation. One of the studies in Kenya
used two criteria (febrile illness and respiratory illness)
in urban site and three criteria (febrile illness, respiratory
illness and hospitalization) in rural sites [13]. Febrile
Fig. 2 Geographical location of population- based longitudinal typhoid fever studies identified based on systematic literature review (Source:
DIVA-GIS (http://www.diva-gis.org))
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Table 2 Typhoid fever annual incidence rate in population-based, longitudinal studies published from 1st January 1990 to 31st December 2013 (not corrected for
blood culture sensitivity)
Location Year Rural/urban Duration
(months)









4 Passive sentinel sites (1 hospital + 11 fever
specialists + 68 health providers + baseline
census + health care utilization adjustment)
≥6mths of age; Current fever of ≥3 days 664,000




5 Passive sentinel (1 hospital + 6 district
hospitals + 16 infectious disease specialists + 13
rural health unit physicians + 18 primary
care providers)
≥1 year age; Current fever of 38 °C







Rural 13 Passive (1 hospital) + health care utilization
adjustment





Sept 2007- July 2009 Rural 23 Passive (1 hospital) + health care utilization
adjustment
<5 years age; hospitalized; every second
case
22,425
Kibera, Kenya March 2007- February
2009
Urban slum 24 Active (field clinic) + biweekly house to house
visit + baseline census + health care utilization
adjustment
All age; Current fever of 38 °C; OR respiratory
illnessd
28,000
Lwak, Kenya October 2006-
September 2009
Rural 36 Active (field clinic) + biweekly house to house
visit + baseline census + health care utilization
adjustment







Rural 12 Passive (three hospital + health care utilization
adjustment)
≥2mts age; Current fever of 37.5.C 500,600
S Asia
New Delhi, India November 1995-
October 1996
Urban slum 12 Active (twice weekly house visit + study
clinic + baseline census)
<40 years;Current fever of 38 °C for <5 years;
Current fever of 38.C for≥ 3 days for >5 years
7159
Kolkata, India November 2003-
October 2004
Urban slum 12 Active (monthly household visit + 2 government
hospitals + 5 study clinics + baseline census)
All age; Febrile ≥ 3 days 56,946
Dhaka, Bangladesh December 2000
-October2001
Urban slum 10 Active (weekly house visit + field clinic + baseline
census)
All age; Current fever of ≥38 °C for <5 years;




Urban slum 12 Active (weekly household visits + field
clinic + baseline census)
All age; Current fever of ≥38 °C for <5 years;
Current fever of ≥38.C for ≥ 3 days for >5 years
26,586
Karachi, Pakistan June 1999-December
2001
Urban 12 Active (fortnightly households visits + two study
clinics + baseline census)
<16 years of age; Febrile ≥ 3 days 41,845
Karachi, Pakistan August 2002-July 2004 Urban slum 30 Active (weekly household visit + three study
clinics +motivation to private providers + baseline
census)







15 Active (weekly household visit + local community
health center + baseline census
<5 years of age; Current fever of 38 °C OR
pneumococcal clinical syndromef
5570
SE & Eastern Asia
Hechi, Guangxi,
China
August 2001-July 2002 Rural +
Urban
12 Passive (5 hospitals + 23 government clinics + 99 private
clinics + baseline census)














Table 2 Typhoid fever annual incidence rate in population-based, longitudinal studies published from 1st January 1990 to 31st December 2013 (not corrected for
blood culture sensitivity) (Continued)
Jakarta, Indonesia August 2002-July 2003 Urban slum 24 Passive (8 government public health centers + 2
government hospitals + baseline census)





Rural 12 Passive (2 health centers + 1 hospital + motivation
to private providers + baseline census)
All age; Current fever of ≥38.C for≥ 3 days 28,329
Hue, Vietnam June 2002-June 2003 Urban 13 Passive (4 hospitals + 32 government clinics + 55
private clinics + baseline census)
5 to 18 years of age; Febrile > 3 days 84,455


















Table 2 Typhoid fever annual incidence rate in population-based, longitudinal studies published from 1st January 1990 to 31st December 2013 (not corrected for





















Belbeis district, Sharkia, Egypt 664,000 449 449 449 664,000 19 6ac 6ac [9]
Fayoum, Egypt 2,240,000 1815 1815 1804 766,540 90 10 29 [10]
Ashanti region, Ghana 9600 1456 1456 1456 4800 7 67 135 [11]
Ashanti region, Ghana 5333 1351 1351 1196 2667 17 166 333 [11, 12]
Kibera, Kenya 54,535e 7852 1531 1531 16,423e 135 248a 822a [13]
Lwak, Kenya 77,017e 11,258 4185 4185 4944e 22 29 445a [13]
Pemba, Zanzibar Tanzania 53,064 3105 2209 2209 38,182 210 4 55a [14]
S Asia
New Delhi, India 6,454e 1454 1217 1217 5402 e 63 880 1166 [17]
Kolkata, India 56,946 4378 4342 4342 56,478 122 214 216 [15]
Dhaka, Bangladesh 12,407e 889 888 888 12,393e 49 474 395 [18]
Dhaka, Bangladesh 19,710e 1333 961 961 14,210e 40 150 282 [30]
Karachi, Pakistan 41,845 7736 7415 7415 40,109 189 452 471 [19]
Karachi, Pakistan 29,170e 4198 1248 1248 8672 e 49 168 565 [15]
Peri-urban Karachi, Pakistan 3,949e 3372 1165 1165 1,364e 16 230 1173 [21]
SE & Eastern Asia
Hechi, Guangxi, China 97,928 1215 1215 1215 97,928 15 15 15 [15]
Jakarta, Indonesia 160,261 6708 5775 5775 137,971 221 69 80 [15, 23]














Table 2 Typhoid fever annual incidence rate in population-based, longitudinal studies published from 1st January 1990 to 31st December 2013 (not corrected for
blood culture sensitivity) (Continued)
Hue, Vietnam 84,455 3678 3611 3611 82,917 18 20 20 [15]
Summary NA 63,220 41,500 41,325 NA 1149 NA NA
NA Not available
aAs reported by authors
bDenominator was corrected for dropout of eligible cases at various level of surveillance starting from health care utilization, referral to health facility, failure to collect blood sample, missing data
cNo correction factor was available
dRespiratory illness was defined for children <5 years old as: cough OR difficulty breathing AND one of the following: convulsions, unable to drink fluids or unable to breastfeed, lethargic, chest in drawing, vomiting
everything, stridor, oxygen saturation <90 %; and for persons ≥5 years old as cough OR difficulty breathing OR chest pain AND one of the following: temperature ≥38.0 °C and oxygen saturation <90 %
eEstimated in person years















criteria had identified only 60 and 27 % of total blood
culture confirmed cases reported in urban and rural sites
respectively. Respiratory criteria had identified additional
38 and 50 % cases in urban and rural sites respectively.
The hospitalization criteria in rural site had identified
additional 23 % of cases. Total 2 % of cases were
detected among persons who did not match any of the
criteria in urban site. The febrile definition of fever of
38 °C for ≥3 days may limit the number of cases identi-
fied as well. The study in Karachi reported that only
24 % of febrile episode identified from house to house
visits had ≥3 days of fever [19] and the rest were not re-
ferred to index surveillance facility. In some other sites
only a proportion of the potential typhoid fever cases are
included. Only hospitalized cases were included in
Agogo study [12] and the researchers estimated that
only 50 % of the cases with inclusion criteria were en-
rolled in the study and applied a correction factor.
Sometimes only a fraction of people identified at com-
munity reach index surveillance facility as observed in
Karachi where 30 % of 4198 febrile illness cases with more
than 3 days of duration presented at the health facility
[19]. Even if febrile illness cases reached health facility, the
blood samples couldn’t be collected from many eligible
cases. In Dhaka, blood samples of only 72 % of eligible
cases could be collected [30] for reasons such as parents
not consenting and unavailability of logistics. Similarly, in
New Delhi blood samples were collected from 84 % of eli-
gible cases [17]. Sometimes a part of the cases are
excluded from analysis because of data related or oper-
ational issues. Nearly 13 % of cases provided blood sam-
ples that were excluded in Agogo study because of
incomplete data [12]. Finally, blood culture does not
detect all typhoid fever cases due to lowered sensitivity re-
lated to duration of illness, amount of sample collected
and problems with blood collection procedure particularly
in younger children as well as prior intake of antibiotics.
Of the 14 studies, eight presented information on prior in-
take of antibiotics [9, 10, 12, 18, 19, 21, 24, 30].
We identified potential resolutions (Table 3) for these
limitations observed in each selected study, and
estimated correction factors to account for under-
estimation. Table 2 illustrates how denominators and
numerators change when these under-estimation limita-
tions are corrected. We present incidence rates using
two methods: a) incidence based on raw surveillance
data, b) surveillance methods adjusted incidence. The in-
cidence rates are very different and amplified when
corrected for surveillance limitations. The corrected in-
cidence data was used in the estimation of global burden
of typhoid fever [32].
We looked at the hospitalization rate in blood culture-
confirmed typhoid cases from 14 selected population-
based studies. The weighted mean hospitalization rates
by regions using random effect models from eight stud-
ies [9, 10, 13, 15, 17, 18, 21, 30, 33] conducted in 13 sites
were presented in Fig. 3. Hospitalization rate was highest
in South-Eastern and Eastern Asia region which had
passive surveillance. Hospitalization was least in
Southern Asia where most sites had active surveil-
lance. The active surveillance studies allow for detec-
tion of less severe cases and also likely to improve
typhoid outcomes by identifying cases early. As ob-
served in Kenya [13], hospitalization rates are likely
to be higher in rural areas with poor access to health-
care, due to delays in receiving appropriate treatment.
Table 3 Common biases in typhoid fever surveillance and potential solutions
Under estimation biases in typhoid fever surveillance Potential solutions
1 All the people in the target community do not visit index facility
used for surveillance
a. Conduct active surveillance by making house to house visit
which is resource intensive but more precise
b. Conduct a census and health care utilization survey, and apply
a correction factor for the underutilization of health facility
2 All people visiting surveillance site and meeting inclusion criteria
are not included in sampling
Estimate what proportion of people with inclusion criteria were
not recruited and apply a correction factor
3 Febrile syndrome does not capture all typhoid fever infected
people because some may not have symptoms severe enough
to be captured and others may be asymptomatic
Broaden the inclusion criteria, particularly for younger children. This
will be resource intensive.
4 Blood samples could not be collected from all eligible cases Document blood sample collection failure along with reasons such
as consent issues and apply a correction factor
5 Could not be included in data analysis for various reasons such as
incomplete data, blood sample contamination
Document dropouts and apply a correction factor it
6 Blood culture does not detect all typhoid fever cases a. Document history of antimicrobial intake prior to blood sample collection
and estimate its relation to culture positivity.
b. Apply a correction factor for blood culture sensitivity based on
best applicable evidence for that settings (e.g. based on empirical
research findings, literature review)
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Of the 14 population-based, longitudinal studies, only
one study had presented any deaths related to typhoid
fever (CFR = 2.6 %; one death in 37 cases) [11].
Discussion
In this systematic literature review we have presented
prospective population-based, blood culture-confirmed
typhoid fever surveillance results. In 24 years’ worth of
literature, beside clinical trials, there were only 14 pub-
lished studies from 15 sites. This indicates typhoid fever
surveillance is not a priority despite millions of people
affected. The information from some parts of the world
such as South America are outdated and generated from
clinical trials. The information from Africa is too min-
imal and comes from four countries only. There are
more sites from Asia, yet its geographical representation
is minimal. Large countries like India have only two
sites. We show that within regions and even within
countries, there is considerable variation in incidence
rate estimates. One can argue that some of the variations
in incidence may be attributed to strength of surveil-
lance system that measured incidence rates. This was
demonstrated at one of the surveillance sites, where in-
volvement of private practitioners resulted in large in-
crease in incidence rates [34].
We listed several critical points that affect the meas-
urement of typhoid fever incidence. This included under
estimation biases resulting from skewed health care
utilization, limitations of eligibility criteria, sampling
limitations, failure to collect blood samples, missing data
and poor sensitivity of blood culture. Here we suggest
how these limitations, if addressed, can improve com-
munity representativeness of surveillance (Table 3).
Surveillance sites not capturing all target population is
one of the key under estimation biases that can be ad-
dressed by adding additional components to the surveil-
lance. A baseline census followed by an active surveillance
where periodic house to house visits are made to ensure
all individuals with inclusion criteria could be identified
and referred to index health facilities eliminates this cav-
eat. An active surveillance allows for the identification of
less clinically severe cases and may yield accurate repre-
sentation of community level incidence. Such studies are
often accompanied by periodic demographic census that
documents migrations, births and deaths in target popula-
tion. Census allows for the accurate measurement of
follow-up period in person years which increases meas-
urement precision. Based on periodic census in Dhaka
study [30], it is reported that on an average individuals
stayed about 10 months in 1 year surveillance. If only one-
time baseline census is conducted one would overestimate
the denominator calculated in person years resulting in
underestimation of the incidence. But active surveillance
needs dedicated staff and costs are high; likely to intro-
duce a bias in typhoid outcomes because cases are identi-
fied quickly and treated. As periodic demographic census
and active surveillance is resource intensive, having a
health care utilization survey along with census is an
Fig. 3 Weighted mean hospitalization rates using random effects model in selected population- based longitudinal typhoid fever studies
classified by regions
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option to lower the cost and reasonable alternative. Based
on a community survey, the study from Zanzibar esti-
mated that only 10.6 % of febrile illness cases in the target
community visited the index surveillance site at Chake
Chake District Hospital and applied a correction factor for
the incidence [14]. Similar health care utilization survey
was used in other sites as well [9, 10, 12, 13].
Surveillance inclusion criteria not capturing all typhoid
fever cases is another key under-estimation bias identified.
Broadening the inclusion criteria to include respiratory ill-
ness and hospitalizations in addition to febrile criteria as
done in Kenya [13] is one approach to capture missing ty-
phoid fever cases. However, these additional inclusion cri-
teria are not specific for typhoid fever, may result in
screening and testing large number of extra cases making
it resource intensive. Besides enhancing the surveillance
intensity, conducting health care utilization and expanding
inclusion criteria, most useful measure that can limit
under estimation bias is good documentation during sur-
veillance (Table 3). It is crucial to carefully document what
proportion of eligible people are a) not visited the surveil-
lance sites, b) not included in the sampling, c) not con-
sented for blood collection, d) could not draw blood
sample, e) dropped out from the analysis. Documenting
the antibiotic intake prior to blood sample collection that
inhibits bacterial growth and correcting for blood culture
sensitivity is another crucial factor. Until recently, most
studies used a correction factor assuming 50 % blood cul-
ture sensitivity [14]. It is not sure if this number accounts
factors that influence blood culture sensitivity. Document-
ing the history of intake of antimicrobials prior to the col-
lection of blood samples and analyzing its implication on
culture positivity is an important measure to understand
blood culture sensitivity. Beyond this, it is crucial to
standardize blood culture methods in multi-site studies
along the side of good measures for quality control. In this
regard, automated blood culture systems such as the
Bactec or other commercial systems may be more reliable
than studies using in-house blood culture methods.
Future studies should consider above limitations in de-
signing the typhoid surveillance so that more precise es-
timation of incidence is possible. One should carefully
plan surveillance to represent community either through
active surveillance approaches, or setting-up of health
facilities close to community for the purpose of case de-
tection, or adjusting for health care utilization of the fa-
cility or by involving most health service providers in
the defined geographical region. Dropouts at different
steps of surveillance process should be documented
carefully so that it can be corrected. As community
based prospective surveillance is basis for global and re-
gional typhoid fever disease burden estimates, correcting
for these factors are essential [32]. The country, regional
and global level disease burden estimates are powerful
information for decisions on policy, financing, vaccin-
ation strategies as well as for advocacy; more precise in-
formation is valuable. Moreover, a new generation
typhoid conjugate vaccine with hopes to have protection
for children <5 years [3], warrants decision makers to
look into new option for typhoid vaccination .
This study has limitations. Our search was confined to
English language only. However, we do not think we
missed many papers because a previous systematic lit-
erature review on typhoid incidence studies [35] did not
find papers in Spanish, Italian, French, and Portuguese
from 1980 to 2009. This review is subjected to publica-
tion biases as we did not search for unpublished infor-
mation. We have presented incidence correction based
on the information reported in the paper and we
couldn’t correct for unreported information or factors
that studies did not mention or accounted for.
Conclusions
In conclusion, longitudinal typhoid fever studies are
available only from selected geographical pockets in low
and middle income countries despite its public health
importance. The incidence is heterogeneous across the
sites, so was the methodology of surveillance which po-
tentially contributed to under estimation biases. Future
longitudinal typhoid fever studies should consider the
methodological limitation presented in this review at
their study design. A precise estimation of typhoid fever
incidence accounting for methodological under estima-
tion has policy, financing and advocacy implications.
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